-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Ixp1r06oZvOPDK/V7UGOOaZN1jBBfgAhAoIxEQ071mPzqHhrAUKOz18VBngfPkbH Fx15ft8z7cOXt3s6Y7LzLg== 0001225208-10-004695.txt : 20100217 0001225208-10-004695.hdr.sgml : 20100217 20100217161332 ACCESSION NUMBER: 0001225208-10-004695 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20100210 FILED AS OF DATE: 20100217 DATE AS OF CHANGE: 20100217 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BOSTON SCIENTIFIC CORP CENTRAL INDEX KEY: 0000885725 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 042695240 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE BOSTON SCIENTIFIC PL CITY: NATICK STATE: MA ZIP: 01760-1537 BUSINESS PHONE: 5086508000 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lance Jean Fitterer CENTRAL INDEX KEY: 0001483825 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-11083 FILM NUMBER: 10612954 MAIL ADDRESS: STREET 1: C/O BOSTON SCIENTIFIC STREET 2: ONE BOSTON SCIENTIFIC PLACE CITY: NATICK STATE: MA ZIP: 01760 3 1 doc3.xml X0203 3 2010-02-10 0 0000885725 BOSTON SCIENTIFIC CORP BSX 0001483825 Lance Jean Fitterer ONE BOSTON SCIENTIFIC PLACE NATICK MA 01760-1537 1 SVP & Chief Compliance Officer Common Stock 48117 D Common Stock 3922 I By 401(k) Deferred Stock Units Common Stock 33119 D Stock Option (Right to Buy) 6.125 2010-12-06 Common Stock 26668 D Stock Option (Right to Buy) 8.3 2019-02-24 Common Stock 33512 D Stock Option (Right to Buy) 8.5 2010-07-25 Common Stock 30000 D Stock Option (Right to Buy) 12.5 2011-12-17 Common Stock 15000 D Stock Option (Right to Buy) 14.1563 2010-05-09 Common Stock 24200 D Stock Option (Right to Buy) 21.255 2012-12-09 Common Stock 16000 D Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan. Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. Reflects multiple DSU awards with independent vesting schedules. Grant to the reporting person on December 6, 2000, of an option to purchase 80,000 shares of common stock. This grant is fully vested. Grant to the reporting person of an option to purchase 33,512 shares of common stock vesting in four equal annual increments beginning on February 24, 2010, the first anniversary of the grant. Grant to the reporting person on July 25, 2000, of an option to purchase 30,000 shares of common stock. This grant is fully vested. Grant to the reporting person on December 17, 2001, of an option to purchase 15,000 shares of common stock. This grant is fully vested. Grant to the reporting person on May 9, 2000, of an option to purchase 24,200 shares of common stock. This grant is fully vested. Grant to the reporting person on December 9, 2002, of an option to purchase 16,000 shares of common stock. This grant is fully vested. lancepoa.TXT /s/ Lawrence J. Knopf, Attorney-in-fact 2010-02-17 EX-24 2 lancepoa.txt POWER OF ATTORNEY Know all by these presents, that the undersigned hereby constitutes and appoints each of Timothy A. Pratt, Lawrence J. Knopf, Anne M. Thompson, Rhonda E. Payne and Ann C. Brachman,signing singly, the undersigned's true and lawful attorney-in-fact to: (1) execute for and on behalf of the undersigned, in the undersigned's capacity as an executive officer and/or director of Boston Scientific Corporation (the "Company"), Forms 3, 4 and 5, and amendments thereto,in accordance with Section 16(a) of the Securities Exchange Act of 1934 and the rules thereunder; (2) do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4 or 5 and file such form with the United States Securities and Exchange Commission and any stock exchange or similar authority; (3) execute for and on behalf of the undersigned, in the undersigned's capacity as an executive officer and/or director of the Company, Forms 144 in accordance with Rule 144 of the Securities Exchange Act of 1933, as amended and the rules and regulations thereunder; and (4) take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact's discretion. The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with Section 16 of the Securities Exchange Act of 1934 or Rule 144 of the Securities Act of 1933, as amended. This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4 and 5 and Forms 144 with respect to the undersigned's holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact. IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 10th day of February, 2010. /s/ Jean Fitterer Lance Jean Fitterer Lance -----END PRIVACY-ENHANCED MESSAGE-----